NCT05359692
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05359692
Title INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Incyte Biosciences International Sarl
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field